GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » China Resources Boya Bio-pharmaceutical Group Co Ltd (SZSE:300294) » Definitions » Purchase Of Property, Plant, Equipment

China Resources Boya Bio-pharmaceutical Group Co (SZSE:300294) Purchase Of Property, Plant, Equipment : ¥-85 Mil (TTM As of Mar. 2024)


View and export this data going back to 2012. Start your Free Trial

What is China Resources Boya Bio-pharmaceutical Group Co Purchase Of Property, Plant, Equipment?

China Resources Boya Bio-pharmaceutical Group Co's purchase of property, plant, equipment for the three months ended in Mar. 2024 was ¥-21 Mil. It means China Resources Boya Bio-pharmaceutical Group Co spent ¥21 Mil on purchasing property, plant, equipment. China Resources Boya Bio-pharmaceutical Group Co's purchase of property, plant, equipment for the trailing twelve months (TTM) ended in Mar. 2024 was ¥-85Mil.

Compared with last quarter (¥-13 Mil in Dec. 2023 ), China Resources Boya Bio-pharmaceutical Group Co spent more money on purchasing property, plant, equipment in Mar. 2024 (¥-21 Mil).


China Resources Boya Bio-pharmaceutical Group Co Purchase Of Property, Plant, Equipment Historical Data

The historical data trend for China Resources Boya Bio-pharmaceutical Group Co's Purchase Of Property, Plant, Equipment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Resources Boya Bio-pharmaceutical Group Co Purchase Of Property, Plant, Equipment Chart

China Resources Boya Bio-pharmaceutical Group Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Purchase Of Property, Plant, Equipment
Get a 7-Day Free Trial Premium Member Only Premium Member Only -88.61 -142.51 -68.12 -138.41 -87.50

China Resources Boya Bio-pharmaceutical Group Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Purchase Of Property, Plant, Equipment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -23.34 -31.85 -19.36 -12.94 -21.18

China Resources Boya Bio-pharmaceutical Group Co Purchase Of Property, Plant, Equipment Calculation

The amount used to purchase PPE.

Purchase Of Property, Plant, Equipment for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-85 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


China Resources Boya Bio-pharmaceutical Group Co Purchase Of Property, Plant, Equipment Related Terms

Thank you for viewing the detailed overview of China Resources Boya Bio-pharmaceutical Group Co's Purchase Of Property, Plant, Equipment provided by GuruFocus.com. Please click on the following links to see related term pages.


China Resources Boya Bio-pharmaceutical Group Co (SZSE:300294) Business Description

Traded in Other Exchanges
N/A
Address
Number 333, Huiquan Road, High-tech Industrial Park, Jiangxi Province, Fuzhou, CHN, 344000
China Resources Boya Bio-pharmaceutical Group Co Ltd is a China-based medical industry group that integrates biochemical drugs, chemical drugs, and active pharmaceutical ingredients. It is engaged in the provision of medical and health products and services. The product categories of the company include blood products, biochemical drugs, chemical medicines and others. Some of the company's blood products include human albumin, rabies immunoglobulin, intravenous human immunoglobulin and human fibrinogen.

China Resources Boya Bio-pharmaceutical Group Co (SZSE:300294) Headlines

No Headlines